HIV/AIDS sufferers in Brazil today get the same treatment as HIV/AIDS sufferers in the USA and Europe - the same, free 'triple cocktail' of anti-retroviral (ARV) drugs, the same clinical care, the same monitoring...Brazil is breaking the virtual price monopoly enjoyed under World Trade Agreements by the major pharmaceuticals companies.